25 Feb 2026Open access
Evaluation of the concordance between nasopharyngeal and oropharyngeal swabs in the detection of COVID-19Publisher siteJournal of Public Health in Africa, SARS-CoV-2 detection and testing
Active, last published 2026
In covid-19 clinical research studies
Willy Leroi Togna
Pabo
Scholar“Research focused on COVID-19 Clinical Research Studies and adjacent fields.”
University of Buea
Cameroon
Claim Your ProfileCameroon2
H-index
20
Citations
Willy has not officially claimed their profile. If you are Willy, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
illy Leroi Togna Pabo is a researcher working on COVID-19 Clinical Research Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Willy's work has been cited 20 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
COVID-19 Clinical Research Studies×3SARS-CoV-2 detection and testing×2HIV/AIDS Research and Interventions×2HIV Research and Treatment×2HIV/AIDS drug development and treatment×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Buea, CameroonDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
4 works5 May 2025Open access
Viral dynamics and factors associated with duration of COVID-19 positivity: evidence from the first-three epidemiological waves in CameroonPublisher siteBMC Infectious Diseases, SARS-CoV-2 detection and testing
1 Mar 2024Open access1cites
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan AfricaPublisher siteJournal of Virus Eradication, HIV Research and Treatment
1 Jan 2024Open access4cites
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in CameroonPublisher siteJournal of the International Association of Providers of AIDS Care (JIAPAC), HIV/AIDS drug development and treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Willy?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you